HeraMED - Crunchbase Company Profile & Funding

Q: Where is HeraMED's headquarters?

HeraMED is located in Netanya, HaMerkaz, Israel.

Q: When was the last funding round for HeraMED?

HeraMED closed its last funding round on obfuscated from a Post-IPO Equity round.

Overview

HeraMED

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About HeraMED

CB Rank

208076

HeraMED is a technology company that develops and sells smartphone-based pregnancy monitoring solutions.

Founded

obfuscation

Public

Post-IPO Equity

Netanya, HaMerkaz, Israel

11-50

www.hera-med.com/

Biotechnology

Electronics

Health Care

Information Technology

Software

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Details

Legal Name

HeraMED Limited

Operating Status

Active

Stock Symbol

ASX:HMD

Company Type

For Profit

Founders

David Groberman, Tal Slonim

About the Company

HeraMED is a technology start-up developing innovative mHealth pregnancy monitoring solutions. The company has recently completed development of the first medical grade, smartphone based fetal wellness monitor for home use.

Predictions & Insights

Growth Insight

See this Growth Insight

HeraMED is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

HeraCARE

A cloud-based remote maternity care platform for managing pregnancy and postpartum monitoring, enabling providers to oversee patients remotely via a dashboard and patients to follow personalized care plans through a mobile app.

HeraBEAT

A medical-grade, smartphone-connected fetal and maternal heart rate monitor that enables expectant mothers and providers to measure and track fetal heart rate remotely using ultrasound Doppler technology.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - HeraMED	—	obfuscated obfuscation	—	Post-IPO Equity